Kanesa-thasan Niranjan's Form 4 filing
Icosavax, Inc.ICVX · filed Aug 2, 2021
- Accession no.
- 0000899243-21-031137
- Filed
- Aug 2, 2021
- Trade date
- Jul 30-Aug 2, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $100.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kanesa-thasan NiranjanCIK 0001874021 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock | PPurchaseAcquired | +6,666 | $15.00 | +$99,990 | 6,666 | Direct | |
| Jul 30, 2021 | Common Stock | AGrant or awardAcquired | +41,500 | $15.00 | +$622,500 | 168,656 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.